Novel Allosteric Effectors Targeting Human Transcription Factor TEAD
International Journal of Molecular Sciences · 19.05.2023 · 24 (10) · 9009
DOI: 10.3390/ijms24109009 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.05.2023. Verfasst von Mayar Tarek Ibrahim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Center for Research Computing, Center for Drug Discovery, Design, and Delivery (CD4), Southern Methodist University, Dallas,…. Hauptthemen laut MEDLINE: Transcription Factors, DNA-Binding Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences of the National Institutes of Health.
Abstract (Originalsprache)
The Hippo pathway is an evolutionary conserved signaling network involved in several cellular regulatory processes. Dephosphorylation and overexpression of Yes-associated proteins (YAPs) in the Hippo-off state are common in several types of solid tumors. YAP overexpression results in its nuclear translocation and interaction with transcriptional enhanced associate domain 1-4 (TEAD1-4) transcription factors. Covalent and non-covalent inhibitors have been developed to target several interaction sites between TEAD and YAP. The most targeted and effective site for these developed inhibitors is the palmitate-binding pocket in the TEAD1-4 proteins. Screening of a DNA-encoded library against the TEAD central pocket was performed experimentally to identify six new allosteric inhibitors. Inspired by the structure of the TED-347 inhibitor, chemical modification was performed on the original inhibitors by replacing secondary methyl amide with a chloromethyl ketone moiety. Various computational tools, including molecular dynamics, free energy perturbation, and Markov state model analysis, were employed to study the effect of ligand binding on the protein conformational space. Four of the six modified ligands were associated with enhanced allosteric communication between the TEAD4 and YAP1 domains indicated by the relative free energy perturbation to original molecules. Phe229, Thr332, Ile374, and Ile395 residues were revealed to be essential for the effective binding of the inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Center for Research Computing, Center for Drug Discovery, Design, and Delivery (CD4), Southern Methodist University, Dallas, TX 75205, USA.
- Graduate Program in Computational and Data Sciences, Schmid College of Science and Technology, Chapman University, Orange, CA 92866, USA.
- Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, CA 92618, USA.
- Department of Biological Sciences, University of Texas at Dallas, Richardson, TX 75080, USA.
ORCID-Profile: Gennady M Verkhivker
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences of the National Institutes of Health
Zitieren
APA
Ibrahim, M. T., Verkhivker, G. M., Misra, J., & Tao, P. (2023). Novel Allosteric Effectors Targeting Human Transcription Factor TEAD. International Journal of Molecular Sciences, 24(10), 9009. https://doi.org/10.3390/ijms24109009
Vancouver
Ibrahim MT, Verkhivker GM, Misra J, Tao P. Novel Allosteric Effectors Targeting Human Transcription Factor TEAD. International Journal of Molecular Sciences. 2023;24(10):9009. doi:10.3390/ijms24109009
BibTeX
@article{Ibrahim2023,
author = {Ibrahim, Mayar Tarek and Verkhivker, Gennady M and Misra, Jyoti and Tao, Peng},
title = {Novel Allosteric Effectors Targeting Human Transcription Factor TEAD},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {10},
pages = {9009},
doi = {10.3390/ijms24109009}
}
EUVIMED